Company / R&D Expense
PURE BIOSCIENCE, INC. R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$316.0K
FY2025
5-year range
$297.0K / $339.0K
FY2021-FY2025
Trend
+4.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has fluctuated over the past 10 years, ranging from $297,000 in FY2023 to $927,000 in FY2016.
Based on SEC 10-K filings.
$316,000 in FY2025 with a 5-year CAGR of -0.4%.
Improved from $297,000 to $316,000 over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -0.3%
- 5-Year CAGR
- -0.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -0.4%, indicating a declining trend.
- In FY2025, r&d expense increased 4.6% year-over-year.
- Peak r&d expense was recorded in FY2016.
- Lowest r&d expense in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -116.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $316.0K | +4.6% |
| FY2024 | $302.0K | +1.7% |
| FY2023 | $297.0K | -6.9% |
| FY2022 | $319.0K | -5.9% |
| FY2021 | $339.0K | +5.3% |
| FY2020 | $322.0K | -9.0% |
| FY2019 | $354.0K | -22.9% |
| FY2018 | $459.0K | -41.1% |
| FY2017 | $779.0K | -16.0% |
| FY2016 | $927.0K | +17.3% |
As of FY2025 · SEC Form 10-K · Last checked Jun 29, 2026